AB003. OA01.03: Comparison of Two Assessment Criteria for Thymic Epithelial Tumors after Chemoradiotherapy

Kailiang Wu,Xingwen Fan,Yu Yang,Hongbing Wang
DOI: https://doi.org/10.21037/med.2018.ab003
2018-01-01
Mediastinum
Abstract:Background: Measuring tumor response to treatment is important for both clinical decision-making and multi-institutional studies. There are two radiographic assessment criteria of treatment response for thymic epithelial tumors (TET): Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST 1.1) and International Thymic Malignancy Interest Group (ITMIG) modified criteria. This study was to compare these two assessment criteria for TET treated with chemoradiotherapy.
What problem does this paper attempt to address?